[ Price : $8.95]
An Illinois federal judge fines Boehringer Ingelheim $931,000 over Pradaxa development and marketing files it is unable to produce...[ Price : $8.95]
FDA medical reviewers say they cant be certain from updated study information that Bristol-Myers Squibbs diabetes drug dapaglifloz...[ Price : $8.95]
FDA asks antimicrobial drug manufacturers to revise their labels under a voluntary plan to help phase out human-use antibiotics in...[ Price : $8.95]
FDA asks for labeling changes in all OTC topical antiseptic drug products indicated for preoperative or pre-injection skin prepara...[ Price : $8.95]
FDA approves a six-month priority review for Genzymes NDA for Cerdelga to treat adult patients with Gaucher Disease Type 1.[ Price : $8.95]
CSL Behring tells FDA it opposes a citizen petition asking the agency to impose new safety measures on Berinert and Cinryze.[ Price : $8.95]
Advamed praises a bipartisan federal budget deal that would release user fees that were caught up in the sequestration and repeal ...[ Price : $8.95]
Orexigen Therapeutics resubmits its NDA for weight-loss drug Contrave (naltrexone/bupropion) after reporting last month a positive...